Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 04:00PM ET
9.33
Dollar change
-0.08
Percentage change
-0.85
%
IndexRUT P/E- EPS (ttm)-0.63 Insider Own30.97% Shs Outstand97.41M Perf Week0.00%
Market Cap909.35M Forward P/E- EPS next Y-1.69 Insider Trans-0.10% Shs Float67.28M Perf Month250.75%
Income-60.76M PEG- EPS next Q-0.33 Inst Own55.76% Short Float6.85% Perf Quarter240.51%
Sales150.86M P/S6.03 EPS this Y48.36% Inst Trans1.02% Short Ratio4.14 Perf Half Y236.82%
Book/sh0.90 P/B10.42 EPS next Y-138.16% ROA-20.39% Short Interest4.61M Perf Year212.04%
Cash/sh2.37 P/C3.94 EPS next 5Y2.70% ROE-57.63% 52W Range1.87 - 9.44 Perf YTD177.68%
Dividend Est.- P/FCF- EPS past 5Y-12.83% ROI-37.08% 52W High-1.17% Beta1.64
Dividend TTM- Quick Ratio3.20 Sales past 5Y53.46% Gross Margin96.38% 52W Low398.93% ATR (14)0.48
Dividend Ex-Date- Current Ratio3.20 EPS Y/Y TTM57.79% Oper. Margin-41.43% RSI (14)88.59 Volatility0.91% 7.94%
Employees330 Debt/Eq0.95 Sales Y/Y TTM203.18% Profit Margin-40.28% Recom2.60 Target Price9.50
Option/ShortYes / Yes LT Debt/Eq0.88 EPS Q/Q160.24% Payout- Rel Volume1.08 Prev Close9.41
Sales Surprise341.53% EPS Surprise150.30% Sales Q/Q667.19% EarningsNov 07 AMC Avg Volume1.11M Price9.33
SMA2078.51% SMA50156.90% SMA200195.87% Trades Volume1,202,555 Change-0.85%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Downgrade Piper Sandler Overweight → Neutral $10
Jan-04-23Initiated H.C. Wainwright Buy $15
Jan-07-22Initiated Cantor Fitzgerald Overweight $24
May-18-21Initiated BTIG Research Buy $40
Aug-04-20Initiated William Blair Outperform
Aug-04-20Initiated Piper Sandler Overweight $30
Aug-04-20Initiated BofA Securities Buy $20
Nov-28-24 09:55AM
Nov-27-24 09:55AM
09:15AM
06:50AM
Nov-26-24 11:10AM
09:07AM Loading…
09:07AM
06:19AM
05:47AM
03:54AM
01:28AM
01:10AM
01:10AM
Nov-14-24 09:00AM
Nov-12-24 12:00PM
Nov-11-24 04:05PM
05:55PM Loading…
Nov-07-24 05:55PM
04:05PM
Nov-05-24 04:05PM
Oct-24-24 08:00AM
Oct-17-24 08:00AM
Oct-15-24 08:05AM
Oct-03-24 04:30PM
Sep-27-24 04:30PM
Sep-17-24 04:12AM
Sep-16-24 08:00AM
Sep-05-24 09:00AM
Sep-04-24 04:05PM
Aug-29-24 04:05PM
Aug-05-24 09:55PM
05:55PM
04:05PM Loading…
04:05PM
Jul-19-24 12:00PM
Jul-01-24 04:05PM
Jun-03-24 04:05PM
May-14-24 09:53PM
05:08PM
04:05PM
May-09-24 09:00AM
May-02-24 06:22AM
06:04AM
May-01-24 09:30PM
05:42AM
Apr-18-24 08:00AM
Apr-17-24 09:00AM
Apr-08-24 12:00PM
Apr-01-24 04:05PM
Mar-25-24 04:05PM
Mar-19-24 04:05PM
Mar-13-24 04:05PM
Mar-07-24 10:53PM
10:45PM
06:55PM
04:07PM
Mar-04-24 04:05PM
Jan-04-24 08:00AM
Dec-10-23 12:00PM
Nov-17-23 01:08PM
Nov-09-23 04:05PM
Nov-07-23 08:00AM
Nov-02-23 10:00AM
09:01AM
Oct-16-23 12:00PM
Oct-09-23 04:30PM
Oct-03-23 05:00PM
Sep-05-23 08:00AM
Aug-10-23 06:02AM
Aug-08-23 05:40PM
04:05PM
Aug-07-23 09:01AM
09:00AM
Jul-31-23 08:23AM
Jul-05-23 08:00AM
Jun-26-23 08:00AM
Jun-01-23 08:00AM
May-23-23 08:00AM
May-22-23 08:00AM
May-18-23 08:00AM
May-11-23 06:11AM
May-10-23 12:00PM
May-09-23 07:05PM
04:05PM
May-02-23 04:30PM
May-01-23 08:00AM
Apr-17-23 06:48AM
Apr-13-23 08:00AM
Apr-11-23 04:05PM
08:00AM
Apr-03-23 07:09AM
Mar-09-23 06:05PM
04:05PM
Mar-01-23 08:00AM
Feb-22-23 08:00AM
Feb-21-23 06:50AM
Feb-15-23 08:50AM
Feb-14-23 08:00AM
Feb-08-23 08:00AM
Jan-31-23 04:05PM
Jan-27-23 08:50AM
Jan-25-23 11:16AM
Jan-10-23 08:50AM
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gergen Mark JExecutive ChairmanNov 26 '24Option Exercise2.7830,00083,430681,291Nov 27 07:39 PM
Gergen Mark JExecutive ChairmanNov 26 '24Sale9.2730,000278,100651,291Nov 27 07:39 PM
MARK GERGENDirectorNov 26 '24Proposed Sale2.86120,000343,200Nov 26 04:22 PM